Adherence, Diversion, & Misuse

For the prevention of and response to diversion (i.e. selling or sharing of medications) or misuse (i.e. taking medication in a manner other than prescribed) of medications to treat opioid use disorder.

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.